AllianceBernstein’s Ironwood Pharmaceuticals IRWD Stock Holding History

AllianceBernstein’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$559K	Sell	165,790 -33,730	-17%	-$138K	﹤0.01%	2584
2025 Q4	$672K	Hold	199,520	–	–	﹤0.01%	2517
2025 Q3	$261K	Hold	199,520	–	–	﹤0.01%	2987
2025 Q2	$143K	Buy	199,520 +46,960	+31%	+$36.9K	﹤0.01%	3118
2025 Q1	$224K	Sell	152,560 -10,510	-6%	-$25K	﹤0.01%	2885
2024 Q4	$722K	Hold	163,070	–	–	﹤0.01%	2487
2024 Q3	$672K	Hold	163,070	–	–	﹤0.01%	2514
2024 Q2	$1.06M	Hold	163,070	–	–	﹤0.01%	2268
2024 Q1	$1.42M	Sell	163,070 -3,861	-2%	-$46.9K	﹤0.01%	2093
2023 Q4	$1.91M	Buy	166,931 +5,900	+4%	+$58.4K	﹤0.01%	1963
2023 Q3	$1.55M	Hold	161,031	–	–	﹤0.01%	2015
2023 Q2	$1.71M	Hold	161,031	–	–	﹤0.01%	1990
2023 Q1	$1.69M	Sell	161,031 -41,196	-20%	-$461K	﹤0.01%	1964
2022 Q4	$2.51M	Buy	202,227 +139	+0.1%	+$1.58K	﹤0.01%	1787
2022 Q3	$2.09M	Sell	202,088 -26,212	-11%	-$297K	﹤0.01%	1857
2022 Q2	$2.63M	Sell	228,300 -4,921	-2%	-$58K	﹤0.01%	1779
2022 Q1	$2.93M	Sell	233,221 -8,300	-3%	-$95.1K	﹤0.01%	1863
2021 Q4	$2.82M	Sell	241,521 -58,304	-19%	-$715K	﹤0.01%	1942
2021 Q3	$3.92M	Buy	299,825 +54,504	+22%	+$704K	﹤0.01%	1737
2021 Q2	$3.16M	Buy	245,321 +20,100	+9%	+$230K	﹤0.01%	1903
2021 Q1	$2.52M	Sell	225,221 -82,310	-27%	-$870K	﹤0.01%	1959
2020 Q4	$3.5M	Buy	307,531 +43,410	+16%	+$475K	﹤0.01%	1692
2020 Q3	$2.38M	Sell	264,121 -5,900	-2%	-$58.6K	﹤0.01%	1756
2020 Q2	$2.79M	Buy	270,021 +26,261	+11%	+$269K	﹤0.01%	1655
2020 Q1	$2.46M	Buy	243,760 +4,800	+2%	+$56.4K	﹤0.01%	1551
2019 Q4	$3.18M	Hold	238,960	–	–	﹤0.01%	1693
2019 Q3	$2.05M	Hold	238,960	–	–	﹤0.01%	1901
2019 Q2	$2.61M	Sell	238,960 -2,897	-1%	-$32.5K	﹤0.01%	1808
2019 Q1	$2.74M	Hold	241,857	–	–	﹤0.01%	1736
2018 Q4	$2.1M	Hold	241,857	–	–	﹤0.01%	1803
2018 Q3	$3.74M	Hold	241,857	–	–	﹤0.01%	1488
2018 Q2	$3.87M	Hold	241,857	–	–	﹤0.01%	1426
2018 Q1	$3.13M	Hold	241,857	–	–	﹤0.01%	1515
2017 Q4	$3.04M	Sell	241,857 -3,701	-2%	-$48.3K	﹤0.01%	1557
2017 Q3	$3.24M	Sell	245,558 -29,850	-11%	-$411K	﹤0.01%	1506
2017 Q2	$4.36M	Sell	275,408 -105,287	-28%	-$1.53M	﹤0.01%	1289
2017 Q1	$5.44M	Sell	380,695 -104,988	-22%	-$1.44M	﹤0.01%	1151
2016 Q4	$6.22M	Buy	485,683 +218,633	+82%	+$2.76M	0.01%	1080
2016 Q3	$3.55M	Hold	267,050	–	–	﹤0.01%	1340
2016 Q2	$2.92M	Buy	267,050 +18,507	+7%	+$181K	﹤0.01%	1393
2016 Q1	$2.28M	Hold	248,543	–	–	﹤0.01%	1503
2015 Q4	$2.41M	Hold	248,543	–	–	﹤0.01%	1463
2015 Q3	$2.17M	Sell	248,543 -287	-0.1%	-$2.68K	﹤0.01%	1583
2015 Q2	$2.51M	Hold	248,830	–	–	﹤0.01%	1606
2015 Q1	$3.33M	Hold	248,830	–	–	﹤0.01%	1377
2014 Q4	$3.19M	Hold	248,830	–	–	﹤0.01%	1401
2014 Q3	$2.7M	Hold	248,830	–	–	﹤0.01%	1493
2014 Q2	$3.19M	Buy	248,830 +16,714	+7%	+$182K	﹤0.01%	1424
2014 Q1	$2.4M	Buy	232,116 +30,569	+15%	+$344K	﹤0.01%	1576
2013 Q4	$1.96M	Sell	201,547 -11,017	-5%	-$98.9K	﹤0.01%	1719
2013 Q3	$2.11M	Buy	212,564 +1,226	+0.6%	+$12K	﹤0.01%	1631
2013 Q2	$1.76M	Buy	+211,338	New	+$2.56M	﹤0.01%	1698

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein's IRWD Position: Q1 2026 in Review

AllianceBernstein reduced its Ironwood Pharmaceuticals (IRWD) stake by 17% in Q1 2026, selling an estimated $138K and leaving 165,790 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #2584.

AllianceBernstein first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.22M in Q4 2016. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

AllianceBernstein held 165,790 shares of Ironwood Pharmaceuticals worth $559K as of Q1 2026.
AllianceBernstein sold 33,730 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $138K.
Ironwood Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2584 holding.
AllianceBernstein first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
AllianceBernstein's Ironwood Pharmaceuticals position peaked at $6.22M in Q4 2016.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.